A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

Parkinson’s disease and Lewy Body Dementia (LBD) are two serious brain conditions that affect millions of people in the U.S.

Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical ...

Researchers suggest drugs that prevent cholesterol from being converted to 24-OHC might therefore be an effective treatment for Parkinson's disease.

A groundbreaking study by researchers at Wuhan University, China, has identified a cholesterol metabolite that plays a ...

Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical role in the development of Parkinson's disease in mice.

Preventing cholesterol from being converted to 24-OHC might be an effective treatment for Parkinson's, according to the ...

Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical role in the development of ...

Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical ...

Chinese scientists say preventing cholesterol from being converted to 24-OHC might be an effective treatment for Parkinson's disease.

Little is known about a form of dementia that affects more than 100,000 Australians but researchers are looking to build ...

Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated i ...